1,585
Views
1
CrossRef citations to date
0
Altmetric
Letter to the Editor

Prediction of nodule regrowth after radiofrequency ablation of benign thyroid nodules

ORCID Icon &
Pages 11-12 | Received 19 Nov 2020, Accepted 16 Dec 2020, Published online: 05 Jan 2021

References

  • Yan L, Luo Y, Xie F, et al. Residual vital ratio: predicting regrowth after radiofrequency ablation for benign thyroid nodules. Int J Hyperthermia. 2020;37(1):1139–1148.
  • Gharib H, Papini E, Paschke R, et al. American association of clinical endocrinologists, associazione medici endocrinologi, and european thyroid association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. J Endocrinol Invest. 2010;33(5):287–250.
  • Meloni MF, Andreano A, Franza E, et al. Contrast enhanced ultrasound: should it play a role in immediate evaluation of liver tumors following thermal ablation? Eur J Radiol. 2012;81(8):e897-902–e902.
  • Zhang L, Zhou W, Zhan W, et al. Percutaneous laser ablation of unifocal papillary thyroid microcarcinoma: utility of conventional ultrasound and contrast-enhanced ultrasound in assessing local therapeutic response. World J Surg. 2018;42(8):2476–2484.
  • Nikfarjam M, Muralidharan V, Christophi C. Mechanisms of focal heat destruction of liver tumors. J Surg Res. 2005;127(2):208–223.
  • Wu F. Heat-based tumor ablation: role of the immune response. Adv Exp Med Biol. 2016;880:131–153.
  • Ohno T, Kawano K, Sasaki A, et al. Expansion of an ablated site and induction of apoptosis after microwave coagulation therapy in rat liver. J Hepatobiliary Pancreat Surg. 2001;8(4):360–366.
  • Sim JS, Baek JH, Cho W. Initial ablation ratio: quantitative value predicting the therapeutic success of thyroid radiofrequency ablation. Thyroid. 2018;28(11):1443–1449.
  • Albrecht T, Blomley M, Bolondi L, et al. Guidelines for the use of contrast agents in ultrasound. January 2004. Ultraschall Med. 2004;25(4):249–256.
  • Schiaffino S, Serpi F, Rossi D, et al. Reproducibility of ablated volume measurement is higher with contrast-enhanced ultrasound than with b-mode ultrasound after benign thyroid nodule radiofrequency ablation-a preliminary study. J Clin Med. 2020;9(5):1504.
  • Yan L, Luo Y, Xiao J, et al. Non-enhanced ultrasound is not a satisfactory modality for measuring necrotic ablated volume after radiofrequency ablation of benign thyroid nodules: a comparison with contrast-enhanced ultrasound. Eur Radiol. 2020.DOI:https://doi.org/10.1007/s00330-020-07398-0
  • Negro R, Greco G, Deandrea M, et al. Twelve-month volume reduction ratio predicts regrowth and time to regrowth in thyroid nodules submitted to laser ablation: a 5-year follow-up retrospective study. Korean J Radiol. 2020;21(6):764–772.
  • Trimboli P, Castellana M, Sconfienza LM, et al. Efficacy of thermal ablation in benign non-functioning solid thyroid nodule: a systematic review and meta-analysis. Endocrine. 2020;67(1):35–43.